Cancer research firm Prelude Therapeutics recently signed a major lease to locate its future headquarters at the new Chestnut Run Innovation & Science Park (CRISP). | PHOTO COURTESY OF PRELUDE THERAPEUTICS WILMINGTON – Cancer treatment research company Prelude Therapeutics has signed a major lease for its future headquarters at the Chestnut